Based on 2 analysts offering 12 month price targets for Novo Nordisk A S
Min Forecast
$40.00-3.33%
Avg Forecast
$40.00-3.33%
Max Forecast
$40.00-3.33%
Should I buy or sell NVO stock?
Based on 2 analysts offering ratings for Novo Nordisk A S.
Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
1 analysts 50%
Although NVO's forecast from analysts indicates a "Sell", our proven Zen Rating quant model rates NVO as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More
Be the first to know when Wall Street analysts revise their NVO stock forecasts and price targets.
Is Novo Nordisk (Ozempic) Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NYSE: NVO) stock is to Sell NVO stock.
Out of 2 analysts, 0 (0%) are recommending NVO as a Strong Buy, 0 (0%) are recommending NVO as a Buy, 1 (50%) are recommending NVO as a Hold, 0 (0%) are recommending NVO as a Sell, and 1 (50%) are recommending NVO as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year NVO price target, the average NVO price target is $40.00, with the highest NVO stock price forecast at $40.00 and the lowest NVO stock price forecast at $40.00.
On average, Wall Street analysts predict that Novo Nordisk (Ozempic)'s share price could fall to $40.00 by Oct 12, 2027. The average Novo Nordisk (Ozempic) stock price prediction forecasts a potential downside of 3.33% from the current NVO share price of $41.38.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.